Coronavirus vaccines have progressed extraordinarily quickly in reaching the final stages of clinical testing, supporting the possibility that hundreds of millions of doses could be administered in 2021. Learn all about the vaccines on October 5:
Courtesy of Art Caplan; Courtesy of William Haseltine; Courtesy of Maria Elena Bottazzi; Samantha Lee/Business Insiderand start reading now.
Coronavirus vaccines have progressed extraordinarily quickly in reaching the final stages of clinical testing, supporting the possibility that hundreds of millions of doses could be administered in 2021. A vaccine is widely acknowledged as a crucial element in exiting this pandemic. But in order to truly help society, a vaccine needs to be safe, effective and widely available.
Business Insider's healthcare reporter Andrew Dunn will discuss the road ahead for coronavirus vaccines on October 5th at 2:00 p.m. ET.
The panel will discuss what it takes to get a vaccine candidate across the finish line and what happens after that. Even with a safe and effective vaccine, drugmakers and governments will need to collaborate on plans for mass-production, fairly distributing the shot, and convincing the public to get vaccinated. Leading experts will weigh in on the latest challenges and how they are being tackled.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
TikTok employees describe life inside the company as its future hangs in the balance - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »
US widens safety inquiry into AstraZeneca's coronavirus vaccine - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »
Covid vaccine trial 'moving at the speed of science,' not political pressure, Pfizer CEO saysThe head of Pfizer, one of the drugmakers racing to develop a coronavirus vaccine, says the Covid-19 vaccine trial won't be rushed by political pressure.
Read more »
Exclusive: FDA widens U.S. safety inquiry into AstraZeneca coronavirus vaccine - sourcesThe U.S. Food and Drug Administration has broadened its investigation of a serious illness in AstraZeneca Plc&39;s COVID-19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists, three sources familiar with the details told Reuters. AstraZeneca
Read more »
Treasury yields fall as White House confirms President Trump has tested positive for coronavirusU.S. government debt prices rose on Friday following news that President Trump tested positive for coronavirus.
Read more »
Trump says military is prepared to deliver 200,000 coronavirus vaccine doses a dayTrump stood by his November 1 timeline for an effective vaccine and told Fox News' Chris Wallace that once a vaccine is ready, it'll be delivered 'right away.'
Read more »